miércoles, 26 de junio de 2019

Medical News | Medical Articles: Making Bacterial Infections a Thing of the Past for Chronic Respiratory Conditions

Medical News | Medical Articles

 
 June 26, 2019 
 Respiratory Diseases 
 The latest respiratory diseases news from News Medical 
 #ALT#Making Bacterial Infections a Thing of the Past for Chronic Respiratory Conditions

It is possible for CF, COPD and bronchiectasis patients to have a long-term respiratory infection, causing intermittent episodes of exacerbation where their symptoms increase. There are treatments which can be provided long term, but most of these are in cystic fibrosis and are based on inhaled antibiotic therapy. Antimicrobial resistance (AMR) develops in people with cystic fibrosis who receive antibiotics - what is left to determine, is whether resistance predicts response to treatment.



Read Full Article Here
 
   Lung cancer screening using Google AI proves to be successfulLung cancer screening using Google AI proves to be successful
 
Google Artificial Intelligence researchers have developed an algorithm that can detect lung cancers with a 94.4 percent success rate. The results of the study titled, “End-to-end lung cancer screening with three-dimensional deep learning on low-dose chest computed tomography,” were published in the journal Nature Medicine on the 20th of May 2019.
 
   Steroid inhaler may reduce COPD patients' risk of lung cancerSteroid inhaler may reduce COPD patients' risk of lung cancer
 
For many people with chronic obstructive pulmonary disease or COPD, a steroid inhaler is a daily necessity to keep their airways open and help them to breathe. Now, a new UBC analysis shows that these medicated devices may also reduce patients' risk of lung cancer by as much as 30 per cent.
 
 Immunotherapy increases five-year survival rate of patients with advanced non-small cell lung cancer
 
Immunotherapy increases five-year survival rate of patients with advanced non-small cell lung cancerIn a study led by UCLA investigators, treatment with the immunotherapy drug pembrolizumab helped more than 15% of people with advanced non-small cell lung cancer live for at least five years - and 25% of patients whose tumor cells had a specific protein lived at least that long.
 
 
 Radiation associated with increased risk of adverse cardiac events in lung cancer patients
 
Radiation associated with increased risk of adverse cardiac events in lung cancer patientsAs advances in the treatment of non-small cell lung cancer (NSCLC) extend patients' lives, more of these patients are facing a different threat: adverse cardiovascular events, such as heart attacks and heart failure.
 
 
 Three beagles successfully identify lung cancer by scent, shows study
 
Three beagles successfully identify lung cancer by scent, shows studyThree beagles successfully showed they are capable of identifying lung cancer by scent, a first step in identifying specific biomarkers for the disease. Researchers say the dogs' abilities may lead to development of effective, safe and inexpensive means for mass cancer screening.
 
 
 Bad gene associated with sudden death in epilepsy and breathing problems
 
Bad gene associated with sudden death in epilepsy and breathing problemsIn sudden death in epilepsy, people stop breathing for no apparent reason and die. Now, a group of UConn neuroscientists have a lead as to why, they report in the journal eLife. More than one of every 1,000 people with epilepsy die each year from what's called sudden unexpected death in epilepsy (SUDEP). No one knows why.
 

No hay comentarios:

Publicar un comentario